Journal article

The prognostic significance of immune microenvironment in breast ductal carcinoma in situ

MS Toss, A Abidi, D Lesche, C Joseph, S Mahale, H Saunders, T Kader, IM Miligy, AR Green, KL Gorringe, EA Rakha

British Journal of Cancer | SPRINGERNATURE | Published : 2020

Abstract

Background: The role of different subtypes of tumour infiltrating lymphocytes (TILs) in breast ductal carcinoma in situ (DCIS) is still poorly defined. This study aimed to assess the prognostic significance of B and T lymphocytes and immune checkpoint proteins expression in DCIS. Methods: A well characterised DCIS cohort (n = 700) with long-term follow-up comprising pure DCIS (n = 508) and DCIS mixed with invasive carcinoma (IBC; n = 192) were stained immunohistochemically for CD20, CD3, CD4, CD8, FOXP3, PD1 and PDL1. Copy number variation and TP53 mutation status were assessed in a subset of cases (n = 58). Results: CD3+ lymphocytes were the predominant cell subtype in the pure DCIS cohort,..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Ministry of Higher Education and Scientific Research


Funding Acknowledgements

This research was supported and funded by the Egyptian Ministry of Higher Education and Scientific Research. This research was supported by the Peter MacCallum Cancer Foundation and by the National Breast Cancer Foundations (IIRS-18-051).